Webcasts of 3rd EORTC QOL, Symptom Research and Patient Reported Outcomes in Cancer Clinical Trials Conference
11 Apr 2012
View webcasts of the 3rd EORTC QOL, Symptom Research and Patient Reported Outcomes in Cancer Clinical Trials Conference held at the European Parliament on17-19 October 2012.
3rd EORTC Quality of Life, Symptom Research and Patient Reported Outcomes in Cancer Clinical Trials Conference received funding from the European Union in the framework of the Health Programme.
Four investigators received awards during the 3rd Quality of Life Conference closing ceremony
Dr. Andrew Bottomley, conference chair and EORTC Assistant Director, congratulates Joseph O’Connell, Best Oral Presentation by Advanced Career Investigator, and Karoline Albrecht, Best Oral Presentation by Early Career Investigator.
The Best Oral Presentation by an Early Career Investigator was awarded to Ms. Karoline Albrecht from the University of Freiburg Medical Center in Germany for her talk on “HRQOL and side-effects in the course of low-dose interferon therapy in comparison to a control group without interferon”. The Best Oral Presentation by an Advanced Career Investigator was awarded to Dr. Joseph O’Connell from Oncology Research and Development at Pfizer, New York, United States of America, for his talk on “Symptom impact of dacomitinib in patients with advanced lung cancer after chemotherapy failure: results from a phase II randomized trial”. The Best Poster Presentation by Early Career Investigator was awarded to Dr. Emily Symington from the Addenbrookes Cambridge University Hospital in the United Kingdom, and the Best Poster Presentation by an Advanced Career Investigator was awarded to Dr. Amelie Harle from the Christie Hospital in the United Kingdom.
Press releases from the 3rd EORTC Quality of Life, Symptom Research and Patient Reported Outcomes in Cancer Clinical Trials Conference
18 October 2012
- Europe to focus on quality of life in assessing new cancer therapies
- Patient reported outcomes essential for next generation of cancer therapies
19 October 2012
- New data show better quality of life in breast cancer patients is associated with lower BMI, more exercise, responsible alcohol consumption and less loneliness
- Study shows young women with breast cancer have more reproductive concerns and all should be offered fertility preservation counselling
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023